These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10930051)

  • 21. Criteria for the evaluation of studies in transgenic models.
    Popp JA
    Toxicol Pathol; 2001; 29 Suppl():20-3. PubMed ID: 11695558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relevance of rodent tumors in assessing carcinogenicity in human beings.
    Kuschner M
    Regul Toxicol Pharmacol; 1995 Apr; 21(2):250-1. PubMed ID: 7644714
    [No Abstract]   [Full Text] [Related]  

  • 23. Spontaneous nonneoplastic lesions in control Syrian hamsters in three 24-month long-term carcinogenicity studies.
    McInnes EF; Ernst H; Germann PG
    Toxicol Pathol; 2015 Feb; 43(2):272-81. PubMed ID: 24771081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommended tissue list for histopathologic examination.
    Jacobs A; El Hage J; Hastings K; Jacobson-Kram D; Leighton J; Morse D
    Toxicol Pathol; 2003; 31(5):571. PubMed ID: 14692627
    [No Abstract]   [Full Text] [Related]  

  • 25. Alternative mouse models for carcinogenicity assessment: industry use and issues with pathology interpretation.
    Long GG; Morton D; Peters T; Short B; Skydsgaard M
    Toxicol Pathol; 2010 Jan; 38(1):43-50. PubMed ID: 19915137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors influencing carcinogenicity testing in rodents.
    Tucker MJ
    Hum Toxicol; 1987 Mar; 6(2):107-9. PubMed ID: 3557466
    [No Abstract]   [Full Text] [Related]  

  • 27. The Society of Toxicologic Pathology's position on statistical methods for rodent carcinogenicity studies.
    Morton D
    Toxicol Pathol; 2001; 29(6):670-2. PubMed ID: 11794383
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of procedures suggested for reducing the pathology workload in a carcinogenesis testing program.
    Hardisty JF; Ward JM; Douglas JF; Fears TR
    J Environ Pathol Toxicol; 1979 Dec; 3(1-2):167-76. PubMed ID: 397956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and theEnvironment. Statement on ILSI/HESI research programme on alternative cancer models.
    Blain PG
    Toxicol Pathol; 2003; 31(2):254-7. PubMed ID: 12696588
    [No Abstract]   [Full Text] [Related]  

  • 30. Background and framework for ILSI's collaborative evaluation program on alternative models for carcinogenicity assessment. International Life Sciences Institute.
    Robinson DE; MacDonald JS
    Toxicol Pathol; 2001; 29 Suppl():13-9. PubMed ID: 11695549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 26-week Tg.rasH2 mice carcinogenicity studies: microscopic examination of only select tissues in low- and mid-dose groups.
    Paranjpe MG; Denton MD; Elbekai RH
    Toxicol Pathol; 2014 Oct; 42(7):1153-7. PubMed ID: 23960167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
    Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S
    Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RITA--registry of industrial toxicology animal-data--guides for organ sampling and trimming procedures in rats.
    Bahnemann R; Jacobs M; Karbe E; Kaufmann W; Morawietz G; Nolte T; Rittinghausen S
    Exp Toxicol Pathol; 1995 Sep; 47(4):247-66. PubMed ID: 8855121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Society of Toxicologic Pathology's recommendations on statistical analysis of rodent carcinogenicity studies.
    Toxicol Pathol; 2002; 30(3):415-8. PubMed ID: 12051560
    [No Abstract]   [Full Text] [Related]  

  • 35. International Conference on Harmonisation: guidance on testing for carcinogenicity of pharmaceuticals. Notice. Food and Drug Administration, HHS.
    Fed Regist; 1998 Feb; 63(35):8983-6. PubMed ID: 12269370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of rodent carcinogenesis bioassays.
    Ward JM
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):212. PubMed ID: 18029286
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of reduced protocols for carcinogenicity testing of chemicals: report of a joint EPA/NIEHS workshop.
    Lai DY; Baetcke KP; Vu VT; Cotruvo JA; Eustis SL
    Regul Toxicol Pharmacol; 1994 Apr; 19(2):183-201. PubMed ID: 8041916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Using rats from a closed laboratory colony for toxicology tests--pathological view].
    Mimori K
    Exp Anim; 2004 Apr; 53(2):14-20. PubMed ID: 15171238
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparability of results of postnatal and long-term tests for carcinogenicity.
    Sýkora I; Vortel V
    Neoplasma; 1993; 40(5):321-7. PubMed ID: 8272162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay.
    Flammang TJ; Tungeln LS; Kadlubar FF; Fu PP
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):230-40. PubMed ID: 9356286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.